-
Something wrong with this record ?
Carcinogenic pollutants o-nitroanisole and o-anisidine are substrates and inducers of cytochromes P450
H. Rýdlová, M. Miksanová, H. Ryslavá, M. Stiborová
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
16601807
DOI
10.5507/bp.2005.077
Knihovny.cz E-resources
- MeSH
- Aniline Compounds pharmacokinetics pharmacology MeSH
- Anisoles pharmacokinetics pharmacology MeSH
- Enzyme Induction MeSH
- Carcinogens pharmacokinetics pharmacology MeSH
- Rabbits MeSH
- Rats MeSH
- Environmental Pollutants pharmacokinetics pharmacology MeSH
- Microsomes enzymology MeSH
- Rats, Wistar MeSH
- Cytochrome P-450 Enzyme System biosynthesis MeSH
- Animals MeSH
- Check Tag
- Rabbits MeSH
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
2-Methoxyaniline (o-anisidine) and 2-methoxynitrobenzene (o-nitroanisole) are important pollutants and potent carcinogens for rodents. o-Anisidine is oxidized by microsomes of rats and rabbits to N-(2-methoxyphenyl)hydroxylamine that is also formed as the reduction metabolite of o-nitroanisole. o-Anisidine is a promiscuity substrate of rat and rabbit cytochrome P450 (CYP) enzymes, because CYPs of 1A, 2B, 2E and 3A subfamilies oxidize o-anisidine. Using purified CYP enzymes, reconstituted with NADPH: CYP reductase, rabbit CYP2E1 was the most efficient enzyme oxidizing o-anisidine, but the ability of CYP1A1, 1A2, 2B2, 2B4 and 3A6 to participate in o-anisidine oxidation was also proved. Utilizing Western blotting and consecutive immunoquantification employing chicken polyclonal anti bodies raised against various CYPs, the effect of o-anisidine and o-nitroanisole on the expression of the CYP enzymes was investigated. The expression of CYP1A1/2 was found to be strongly induced in rats treated with either compounds. In addition, 7-ethoxyresorufin O-deethylation, a marker activity for both CYP1A1 and 1A2, was significantly increased in rats treated with either carcinogen. The data demonstrate the participation of different rat and rabbit CYP enzymes in o-anisidine oxidation and indicate that both experimental animal species might serve as suitable models to mimic the o-anisidine oxidation in human. Furthermore, by induction of rat hepatic and renal CYP1A1/2, both o-nitroanisole and o-anisidine influence their carcinogenic effects, modifying their detoxification and/or activation pathways.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003721
- 003
- CZ-PrNML
- 005
- 20130311110659.0
- 007
- ta
- 008
- 130128s2005 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2005.077 $2 doi
- 035 __
- $a (PubMed)16601807
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Rýdlová, Helena. $7 _AN071719 $u Department of Biochemistry, Charles University, Prague 2
- 245 10
- $a Carcinogenic pollutants o-nitroanisole and o-anisidine are substrates and inducers of cytochromes P450 / $c H. Rýdlová, M. Miksanová, H. Ryslavá, M. Stiborová
- 520 9_
- $a 2-Methoxyaniline (o-anisidine) and 2-methoxynitrobenzene (o-nitroanisole) are important pollutants and potent carcinogens for rodents. o-Anisidine is oxidized by microsomes of rats and rabbits to N-(2-methoxyphenyl)hydroxylamine that is also formed as the reduction metabolite of o-nitroanisole. o-Anisidine is a promiscuity substrate of rat and rabbit cytochrome P450 (CYP) enzymes, because CYPs of 1A, 2B, 2E and 3A subfamilies oxidize o-anisidine. Using purified CYP enzymes, reconstituted with NADPH: CYP reductase, rabbit CYP2E1 was the most efficient enzyme oxidizing o-anisidine, but the ability of CYP1A1, 1A2, 2B2, 2B4 and 3A6 to participate in o-anisidine oxidation was also proved. Utilizing Western blotting and consecutive immunoquantification employing chicken polyclonal anti bodies raised against various CYPs, the effect of o-anisidine and o-nitroanisole on the expression of the CYP enzymes was investigated. The expression of CYP1A1/2 was found to be strongly induced in rats treated with either compounds. In addition, 7-ethoxyresorufin O-deethylation, a marker activity for both CYP1A1 and 1A2, was significantly increased in rats treated with either carcinogen. The data demonstrate the participation of different rat and rabbit CYP enzymes in o-anisidine oxidation and indicate that both experimental animal species might serve as suitable models to mimic the o-anisidine oxidation in human. Furthermore, by induction of rat hepatic and renal CYP1A1/2, both o-nitroanisole and o-anisidine influence their carcinogenic effects, modifying their detoxification and/or activation pathways.
- 650 _2
- $a aniliny $x farmakokinetika $x farmakologie $7 D000814
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a anisoly $x farmakokinetika $x farmakologie $7 D000840
- 650 _2
- $a karcinogeny $x farmakokinetika $x farmakologie $7 D002273
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x biosyntéza $7 D003577
- 650 _2
- $a látky znečišťující životní prostředí $x farmakokinetika $x farmakologie $7 D004785
- 650 _2
- $a enzymová indukce $7 D004790
- 650 _2
- $a mikrozomy $x enzymologie $7 D008861
- 650 _2
- $a králíci $7 D011817
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Martínková, Markéta $7 xx0105285 $u Department of Biochemistry, Charles University, Prague 2
- 700 1_
- $a Ryšlavá, Helena, $d 1958- $7 uk2007350969 $u Department of Biochemistry, Charles University, Prague 2
- 700 1_
- $a Stiborová, Marie, $d 1950-2020 $7 jo2005259907 $u Department of Biochemistry, Charles University, Prague 2
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 149, č. 2 (2005), s. 441-447
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20130311110913 $b ABA008
- 999 __
- $a ok $b bmc $g 966377 $s 801916
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2005 $b 149 $c 2 $d 441-447 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK111 $a Pubmed-20130128